FDA warns of another compounding pharmacy recall

by Matthew Perrone

BY MATTHEW PERRONE AP HEALTH WRITER WASHINGTON (AP) – The Food and Drug Administration is warning doctors that a compounding pharmacy is recalling dozens of lots of the Roche drug Avastin after receiving reports of eye infections among patients. The FDA said Wednesday that Clinical Specialties of Martinez, Ga. has received five reports of eye infections from physicians who used the drug to treat macular degeneration, a common vision disorder in seniors.
The compounding pharmacy is recalling 40 lots of Avastin distributed to doctors' offices in Georgia, Louisiana, South Carolina and Indiana since December 18, the FDA said in an online posting. Avastin is approved as a cancer drug, but it contains the same active ingredient as Lucentis, another Roche drug approved for macular degeneration. For years, compounding pharmacies have repackaged Avastin into small vials for use by eye doctors. Repackaged injections of Avastin cost about $50, compared with $2,000 for Lucentis. A call placed to Clinical Specialties' lead pharmacist, Austin Gore, was not immediately returned Wednesday. Swiss drugmaker Roche has tried to discourage doctors from using Avastin for such unapproved uses. The company points out that Lucentis was specifically tested and formulated for use in the eye, and its price reflects the cost of that research and development. However, groups like the American Academy of Ophthalmologists say there is no detectable difference in outcomes for patients. More than half the injections given for macular generation in the U.S. are Avastin, according to the group. Age-related macular degeneration is the most common cause of blindness among older Americans, affecting about 2 million people in the U.S. over age 50. The condition causes new blood vessels to grow in the eye and leak blood and fluid, damaging the retina and distorting vision. In recent weeks the FDA has stepped up inspections of compounding pharmacies across a dozen states after a fungal meningitis outbreak last year tied to compounded drugs. A tainted steroid distributed by a Massachusetts-based compounding pharmacy killed 50 people and has sickened more than 720 nationwide. Many of the cases involved a rare form of meningitis tied to fungus found in the New England Compounding Center's facilities. The company has been shut down since the outbreak was discovered in September. ---- © 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.


More Local

Coco's Cupboard

Partnership works to find service dogs for veterans

Dog trainers Suzanne Aaron and Tara Cotton saw many clients who had dogs they just couldn’t handle. They would help the owners find do ... Read More


250 students affected

Homelessness ‘vicious cycle that’s going to continue’

The economy has bounced back from the lows of a few years ago. The housing market is healthy, and the jobless rate has improved. But, for so ... Read More


Annual Sunrise on the Square Road Race a success

The annual Sunrise on the Square included ideal weather and a first-time winner who actually pushed his baby in a stroller. The race, hosted ... Read More


HealthSouth facility scheduled to open Dec. 2

Progress for HealthSouth’s new facility is on track for a Dec. 2 opening, which will add to the town’s growing collection of hea ... Read More


Subsidized medical center proposed for Senoia

Palmetto Health Council is applying for a grant to bring a subsidized medical clinic to Coweta, proposed for the Senoia area. The non-profit ... Read More

Economic Impact

Ports hit new record

The Georgia Ports Authority moved more than 3 million 20-foot equivalent container units in fiscal year 2014 – and set a new record fo ... Read More